Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer

PURPOSE: Currently, treatment recommendations for small-cell urothelial cancer (SCUC) are based on anecdotal case reports and small retrospective series. We now report results from the first phase II clinical trial developed exclusively for SCUC, to our knowledge. PATIENTS AND METHODS: From 2001 to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Siefker-Radtke, Arlene O., Kamat, Ashish M., Grossman, H. Barton, Williams, Dallas L., Qiao, Wei, Thall, Peter F., Dinney, Colin P., Millikan, Randall E.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879720/
https://ncbi.nlm.nih.gov/pubmed/19414678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.0256
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares